Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1452  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


This article has been cited by
1Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis
Rafael da Rosa,Milene Höehr de Moraes,Lara Almida Zimmermann,Eloir Paulo Schenkel,Mario Steindel,Lílian Sibelle Campos Bernardes
European Journal of Medicinal Chemistry.2017;128()25
[DOI]
2Identification of Trypanosoma cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing
Chantal Reigada,Melisa Sayé,Otto Phanstiel,Edward Valera-Vera,Mariana R. Miranda,Claudio A. Pereira
Frontiers in Medicine.2019;6()25
[DOI]
3Identification of Trypanosoma cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing
Solomon Habtemariam
Frontiers in Medicine.2017;6()169
[DOI]
4Identification of potential trypanothione reductase inhibitors among commercially available $$\upbeta $$ ß -carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking
Jorge Rodríguez-Becerra,Lizethly Cáceres-Jensen,José Hernández-Ramos,Lorena Barrientos
Molecular Diversity.2017;21(3)697
[DOI]
5Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of a/ß-peptide foldamers conjugated to cell-penetrating peptides
Héctor de Lucio,Ana María Gamo,Marta Ruiz-Santaquiteria,Sonia de Castro,Pedro A. Sánchez-Murcia,Miguel A. Toro,Kilian Jesús Gutiérrez,Federico Gago,Antonio Jiménez-Ruiz,María-José Camarasa,Sonsoles Velázquez
European Journal of Medicinal Chemistry.2017;140(3)615
[DOI]
6Slow pace of antileishmanial drug development
Awanish Kumar,Satish Chandra Pandey,Mukesh Samant
Parasitology Open.2018;4(3)615
[DOI]
7A Versatile Pre and Post Ugi Modification for the Synthesis of Natural Product Inspired Fused Peptide-Carboline Scaffolds as Potential Anti-Leishmanial Agents
Irfan Khan,Jaybir Singh,Vivek Kumar,Ved Prakash Verma,Monika Shukla,Anupam Dhasmana,Puspendera Singh Naruka,Ajay Kumar Goswami,Keshav Lalit Ameta,Shahnawaz Khan
ChemistrySelect.2019;4(42)12260
[DOI]
8Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme
Lorenzo Turcano,Theo Battista,Esther Torrente De Haro,Antonino Missineo,Cristina Alli,Gicomo Paonessa,Gianni Colotti,Steven Harper,Annarita Fiorillo,Andrea Ilari,Alberto Bresciani,Grace Adira Murilla
PLOS Neglected Tropical Diseases.2020;14(5)e0008339
[DOI]
9Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme
Nilakshi Samaranayake
PLOS Neglected Tropical Diseases.2020;14(5)21
[DOI]
10Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice
Edézio Ferreira Cunha-Júnior,Valter Viana Andrade-Neto,Marta Lopes Lima,Thais Alves da Costa-Silva,Andres J. Galisteo Junior,Maria A. Abengózar,Coral Barbas,Luis Rivas,Elmo Eduardo Almeida-Amaral,Andre Gustavo Tempone,Eduardo Caio Torres-Santos,Michael P Pollastri
PLOS Neglected Tropical Diseases.2017;11(1)e0005281
[DOI]
  Feedback 
  Subscribe 
  Advertise 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal